Bubble CPAP for pneumonia: perils of stopping trials early
- 1 September 2015
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 386 (9998) , 1020-1022
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomised controlled trialThe Lancet, 2015
- CPAP: a guide for clinicians in developing countriesPaediatrics and International Child Health, 2013
- Stopping Randomized Trials Early for Benefit and Estimation of Treatment EffectsSystematic Review and Meta-regression AnalysisJAMA, 2010
- Early stopping of randomized clinical trials for overt efficacy is problematicJournal of Clinical Epidemiology, 2008
- When (Not) to Stop a Clinical Trial for BenefitJAMA, 2005
- The data monitoring experience in the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) programAmerican Heart Journal, 2005
- Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe SepsisJAMA, 2003
- Be skeptical about unexpected large apparent treatment effects:Controlled Clinical Trials, 2003
- Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individualsThe Lancet, 1996
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976